Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: recombinant interleukin-12
Sponsor: Beth Israel Deaconess Medical Center
Collaborators: National Cancer Institute (NCI)